- Home
- ARBE vs LRMR Comparison
ARBE vs LRMR Comparison
Compare ARBE & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- LRMR
- Stock Information
- Founded
- ARBE 2015
- LRMR N/A
- Country
- ARBE Israel
- LRMR United States
- Employees
- ARBE N/A
- LRMR N/A
- Industry
- ARBE EDP Services
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- ARBE Technology
- LRMR Health Care
- Exchange
- ARBE Nasdaq
- LRMR Nasdaq
- Market Cap
- ARBE 203.2M
- LRMR 204.9M
- IPO Year
- ARBE N/A
- LRMR N/A
- Fundamental
- Price
- ARBE $1.21
- LRMR $3.64
- Analyst Decision
- ARBE Buy
- LRMR Strong Buy
- Analyst Count
- ARBE 2
- LRMR 8
- Target Price
- ARBE $1.75
- LRMR $17.88
- AVG Volume (30 Days)
- ARBE 1.2M
- LRMR 1.8M
- Earning Date
- ARBE 08-07-2025
- LRMR 08-14-2025
- Dividend Yield
- ARBE N/A
- LRMR N/A
- EPS Growth
- ARBE N/A
- LRMR N/A
- EPS
- ARBE N/A
- LRMR N/A
- Revenue
- ARBE $536,000.00
- LRMR N/A
- Revenue This Year
- ARBE $285.16
- LRMR N/A
- Revenue Next Year
- ARBE $370.11
- LRMR N/A
- P/E Ratio
- ARBE N/A
- LRMR N/A
- Revenue Growth
- ARBE N/A
- LRMR N/A
- 52 Week Low
- ARBE $0.85
- LRMR $1.61
- 52 Week High
- ARBE $5.09
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- ARBE 30.30
- LRMR 50.06
- Support Level
- ARBE $1.26
- LRMR $3.42
- Resistance Level
- ARBE $1.37
- LRMR $4.41
- Average True Range (ATR)
- ARBE 0.07
- LRMR 0.36
- MACD
- ARBE -0.01
- LRMR -0.03
- Stochastic Oscillator
- ARBE 6.55
- LRMR 34.01
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.